Literature DB >> 18061862

Hereditary ovarian cancer--assessing risk and prevention strategies.

James C Pavelka1, Andrew J Li, Beth Y Karlan.   

Abstract

Hereditary ovarian cancers are almost entirely attributable to mutations in BRCA1/2 or the genes of DNA mismatch repair. Identifying individuals at risk requires a complete family history and evidence-guided genetic testing. Screening of women at increased risk for ovarian cancer can be considered in those not wishing prophylactic surgery and typically should include a twice-annual pelvic examination, serum CA-125 measurement, and transvaginal sonography. Patients must understand that these measures have not been conclusively proven to improve early detection or long-term survival. In all mutation carriers who have completed or do not desire childbearing, prophylactic bilateral salpingo-oophorectomy must be strongly considered.

Entities:  

Mesh:

Year:  2007        PMID: 18061862     DOI: 10.1016/j.ogc.2007.09.005

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  3 in total

1.  Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.

Authors:  G Landon; J Stewart; M Deavers; K Lu; N Sneige
Journal:  Gynecol Oncol       Date:  2012-03-13       Impact factor: 5.482

Review 2.  Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease.

Authors:  Amir A Jazaeri
Journal:  Mol Oncol       Date:  2009-02-07       Impact factor: 6.603

Review 3.  Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment.

Authors:  Concetta Altamura; Maria Raffaella Greco; Maria Rosaria Carratù; Rosa Angela Cardone; Jean-François Desaphy
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.